Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Behav Sleep Med. 2016 Jan 8;15(2):144–157. doi: 10.1080/15402002.2015.1120200

Table 1.

Baseline Participant Characteristics

Exercise (n=10) Non-physical activity (n=7) All Participants
Age, years 61.4 (4.4) 61.9 (4.6) 61.6 (4.3)
Sex 10 females/0 males 6 females/1 male 16 females/1 male
BMI, kg/m2 26.7 (4.9) 27.5 (3.5) 27.0 (4.3)
PSQI Global Score 9.9 (2.3) 8.1 (1.8) 9.2 (2.3)
Sleep latencyacti (minutes) 18.6 (18.6) 25.2 (19.8) 25.8 (18.6)
Sleep durationacti (hours) 5.92 (0.60) 6.22 (1.26) 6.03 (0.88)
WASOacti (minutes) 60.0 (30.0) 55.8 (42.0) 57.0 (34.2)
Sleep efficiencyacti, % 85.1 (6.3) 78.2 (11.3) 82.5 (8.9)
Fragmentation indexacti 35.2 (11.1) 34.8 (13.7) 35.1 (11.8)
Fasting glucose, mg/dL 88.4 (7.1) 91.5 (10.6) 89.6 (8.4)
Fasting insulin, pmol/L 46.5 (21.6) 80.7 (57.4) 60.6 (42.4)
HOMA-IR 10.2 (4.5) 18.4 (14.5) 13.5 (10.4)
HbA1c, % 5.7 (0.4) 6.1 (0.6) 5.8 (0.5)
Pre-sleep Cortisol (μg/dL) 4.2 (2.0) 5.4 (2.8) 4.7 (2.4)
CRP mg/L 0.18 (0.22) 0.47 (.41) 0.34 (.36)

Acti= wrist actigraphy measure. BMI= Body Mass Index; PSQI= Pittsburgh Sleep Quality Index; WASO= Wake After Sleep Onset. HOMA-IR= Homeostatic model of assessment- insulin resistance. CRP= C-reactive protein. Note: Missing data n=2 exercise and n=3 non-physical activity for HbA1c, n= 1 exercise and n=1 non-physical activity for CRP. P values were >0.05 for all comparisons between groups on pre-treatment variables.